- 收听数
- 0
- 性别
- 保密
- 听众数
- 20
- 最后登录
- 2022-12-28
- QQ
 - UID
- 14168
- 阅读权限
- 20
- 帖子
- 261
- 精华
- 0
- 在线时间
- 53 小时
- 注册时间
- 2015-6-17

- 科研币
- 5
- 速递币
- 298
- 娱乐币
- 1721
- 文献值
- 3
- 资源值
- 0
- 贡献值
- 0
|
5速递币
题名 | Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval. | 作者 | Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval. | 杂志 | oncologist | 年|卷|期 | 2018Dec27 | 页码 | epub | 链接 | https://www.ncbi.nlm.nih.gov/pubmed/?term=30591549 |
谢谢大神 |
|